TOTAL Rejects Routine Thrombectomy at PCI for STEMI TOTAL Rejects Routine Thrombectomy at PCI for STEMI
"It seems the message here is that thrombectomy, if it exists at all, would be used in kind of a niche or strategic role, not for all-comers," said one expert not involved in trial. Heartwire from Medscape (Source: theHeart.org)
Source: theHeart.org - March 20, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
The Cardiology Show From ACC 2015 With Dr Valentin FusterThe Cardiology Show From ACC 2015 With Dr Valentin Fuster
PROMISE, PEGASUS, and unpronounceable PCSK9 inhibitors are reviewed, but Dr Fuster was most impressed with the LEGACY data on weight loss in AF. theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - March 17, 2015 Category: Cardiology Tags: Cardiology Roundtable Source Type: news
Genetic Risk Score Could Show Who Benefits Most From Statins Genetic Risk Score Could Show Who Benefits Most From Statins
The genetic risk score, comprising 27 SNPs previously linked with coronary disease in genetic studies, could help risk-stratify patients who would benefit the most from statin therapy. Heartwire from Medscape (Source: theHeart.org)
Source: theHeart.org - March 11, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Longtime Dietary Fat Advice Unsupported by Data: AnalysisLongtime Dietary Fat Advice Unsupported by Data: Analysis
Dietary fat is not the bogeyman it's been made out to be, say researchers. Their advice? Worry less about fat and focus on eating more "real food." Not everyone agrees. Heartwire (Source: theHeart.org)
Source: theHeart.org - February 13, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Many Willing to Die Months Earlier to Avoid Daily Meds: SurveyMany Willing to Die Months Earlier to Avoid Daily Meds: Survey
Cost-effectiveness mavens beware: A substantial minority of adults would pay at least a 1000 bucks or give up 3 months of life to avoid taking a daily pill to prevent CV disease. Heartwire (Source: theHeart.org)
Source: theHeart.org - February 6, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Isolated Systolic Hypertension in Young Adults Ups CVD RiskIsolated Systolic Hypertension in Young Adults Ups CVD Risk
In younger and middle-aged adults, isolated systolic hypertension is not "benign," as many may have thought until now, new research shows. Heartwire (Source: theHeart.org)
Source: theHeart.org - January 30, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
An Interview With PARADIGM HF PI, John McMurrayAn Interview With PARADIGM HF PI, John McMurray
Ileana Piña quizzes the principal investigator for the details of this groundbreaking trial in heart failure. theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - January 28, 2015 Category: Cardiology Tags: Cardiology Commentary Source Type: news
The Human Tales That Keep Me Practicing Medicine The Human Tales That Keep Me Practicing Medicine
When the going gets tough, Dr John Mandrola reflects on the human stories that remind him why he became a doctor. theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - January 21, 2015 Category: Cardiology Tags: Cardiology Expert Column Source Type: news
Heart Disease and Lifestyle: Why Are Doctors in Denial? Heart Disease and Lifestyle: Why Are Doctors in Denial?
Dr John Mandrola asks what it will take to get physicians excited about the role of diet and lifestyle in the prevention and treatment of cardiovascular disease. theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - January 12, 2015 Category: Cardiology Tags: Cardiology Expert Column Source Type: news
Warfarin Time in the Therapeutic Range: Room for ImprovementWarfarin Time in the Therapeutic Range: Room for Improvement
Dr Samuel Goldhaber reviews a study of nationwide management of warfarin for stroke prevention in atrial fibrillation, showing poor real-world TTRs. theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - December 31, 2014 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Cheaper, Faster Clinical TrialsCheaper, Faster Clinical Trials
Bob Harrington and Gregg Stone review the pitfalls of surrogate markers and how to make clinical trials less expensive and more efficient. Can it be done without sacrificing scientific rigor? theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - December 31, 2014 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Where Did the Mitral Regurgitation Go?Where Did the Mitral Regurgitation Go?
Is what you see what you get? Dr Ronald Wharton reviews a curious case of 'disappearing' mitral regurgitation. theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - December 24, 2014 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Bleeding Risk Climbs With Anticoagulant Bridging in AFBleeding Risk Climbs With Anticoagulant Bridging in AF
To bridge or not to bridge? That is the question invoked frequently in clinical practice; another analysis argues against the practice. Upcoming trials could nail down the answer. Heartwire (Source: theHeart.org)
Source: theHeart.org - December 16, 2014 Category: Cardiology Tags: Cardiology News Source Type: news
December 12 Cardiology News PodcastDecember 12 Cardiology News Podcast
Hear a review of the top cardiology stories for the week ending Dec 12 theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - December 12, 2014 Category: Cardiology Tags: Cardiology News Source Type: news
Risks Exceed CV, Cancer Gains from Primary-Prevention ASA: WHS Risks Exceed CV, Cancer Gains from Primary-Prevention ASA: WHS
Doubts about such aspirin therapy were for healthy middle-aged women overall, but aspirin may be warranted in at least one subgroup, suggests an analysis based on the randomized Women's Health Study. Heartwire (Source: theHeart.org)
Source: theHeart.org - December 11, 2014 Category: Cardiology Tags: Cardiology News Source Type: news
